Dynavax Technologies
Biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Launch date
Employees
Market cap
CAD2.0b
Enterprise valuation
CAD1.3b (Public information from Sep 2024)
Share price
$11.5 DVAX
Berkeley California (HQ)
Authorizing premium user...